glp-1 diabetes receptor agonists for individualized treatment of type 2 mellitus GLP-1 trends 2025: real-world data,

For these patients, basal insulin alone may not be the preferred option

In the stomach, stimulation of gastric -cells leads to somatostatin release, resulting in reduced gastric acid secretion and delayed gastric emptying (Figure 1A)

Glucagon-like peptide-1 regulates mitochondrial biogenesis and tau phosphorylation against advanced glycation end product-induced neuronal insult: Studies in vivo and in vitro

DFP and deferasirox (DFX) display improved BBB penetration but carry potential hepatotoxicity and agranulocytosis risks, restricting long-term use (Devos et al., 2014)

Systemic Metabolic Stimulation: Evaluated for its capacity to boost cellular energy expenditure, mitochondrial efficiency, and metabolic regulation

This represents significant savings compared to brand-name options